Scott Schwendiman, MD
Family Medicine · Boise, IDNPI 1538110234
Payments from drug & device makers
Across 85 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$396
- Pfizer$201
- Novo Nordisk$184
- Lilly USA, LLC$117
- Amgen$94
- Stryker$79
- plus $599 from 26 others
What the payments were for
- Consulting fees$201%
- Food & beverage$1,60796%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 10 | $396 |
| Pfizer | 17 | $201 |
| Novo Nordisk | 11 | $184 |
| Lilly USA, LLC | 5 | $117 |
| Amgen | 5 | $94 |
| Stryker | 2 | $79 |
| Astellas Pharma US Inc | 3 | $58 |
| Exact Sciences | 2 | $57 |
| Corium, LLC | 2 | $35 |
| Corcept Therapeutics | 2 | $33 |
| Merck | 2 | $32 |
| AbbVie | 2 | $32 |
| GSK | 2 | $30 |
| Vertex | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Novartis | 1 | $20 |
| Bayer | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Recor Medical Inc | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Exeltis, USA Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Sonex Health, Inc. | 1 | $11 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
| Mayne Pharma Commercial LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,672 in reported general payments places this provider in the 80th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 27 | $38,626 |
| EliquisApixaban | 45 | $33,876 |
| Tresiba Flextouch U-200Insulin Degludec | 20 | $18,131 |
| FarxigaDapagliflozin Propanediol | 15 | $12,247 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,771 |
| Breo ElliptaFluticasone/Vilanterol | 11 | $6,682 |
| Carbamazepine ErCarbamazepine | 22 | $2,485 |
| Levothyroxine Sodium | 188 | $1,952 |
| Estradiol | 16 | $1,680 |
| Omeprazole | 102 | $1,626 |
| Bupropion XlBupropion Hcl | 24 | $1,227 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 39 | $944 |
| Atorvastatin Calcium | 99 | $849 |
| Tamsulosin Hcl | 48 | $705 |
| Rosuvastatin Calcium | 65 | $685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $184 | $38,62627 claims |
| PfizerEliquis | $201 | $33,87645 claims |
| GSKAnoro Ellipta, Breo Ellipta | $30 | $13,45324 claims |
| AstraZenecaFarxiga | $396 | $12,24715 claims |
| Lilly USA, LLCOlanzapine | $117 | $16314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 803 family medicine providers in Idaho.
Other family medicine in Boise
- Brock McConneheyBoise$4.5M
- Diane McConneheyBoise$681K
- Phyllis YouBoise$88K
- John EckBoise$55K
- Kara CadwalladerBoise$24K
- Cyrus VaniaBoise$9K
- Joshua AdamsBoise$8K
- Nicole StiversBoise$7K
- Ammon RobertsBoise$7K
- Mark TurnerMeridian$40.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.